Insider · CIK 0001640861

Nicholson Garry A

Reports to the SEC for 7 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001640861

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-20	TCRXTScan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+67K sh	—	—	67,000
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−33.9K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−37.5K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−32.3K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−33.9K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+33.9K sh	—	—	33,900
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−37.5K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+37.5K sh	—	—	37,500
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−32.3K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+32.3K sh	—	—	32,335
2025-06-30	TCRXTScan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+67K sh	—	—	67,000
2025-06-02	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+22.5K sh	—	—	22,500
2025-06-02	DAWNDay One Biopharmaceuticals, Inc. · Deferred Restricted Stock Unit (RSU)A Award	Director	AAward	+15K sh	—	—	15,000
2024-09-18	G1 Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	14,389
2024-09-18	G1 Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−14.4K sh	—	—	0
2024-09-18	G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2024-09-18	G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2024-09-18	G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2024-06-13	G1 Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	34,389
2024-06-13	G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-06-12	TCRXTScan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+47.5K sh	—	—	47,500
2024-06-12	TCRXTScan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.8K sh	—	—	23,750
2024-05-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+32.3K sh	—	—	32,335
2023-06-22	DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award	Director	AAward	+37.5K sh	—	—	37,500
2023-06-22	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2023-06-15	G1 Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	24,389
2023-06-15	G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-09-12	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (Right to buy Common Stock)A Award	Director	AAward	+33.9K sh	—	—	33,900
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.4K sh	—	—	0
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,500 sh	—	—	0
2022-06-23	G1 Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	14,389
2022-06-23	G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-06-23	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2021-06-24	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2021-06-17	G1 Therapeutics, Inc.A Award	Director	AAward	+4,389 sh	—	—	4,389
2021-06-17	G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+19.6K sh	—	—	19,620
2021-06-02	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2020-06-15	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2020-06-15	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+23.4K sh	—	—	23,400
2020-06-11	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-11	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.1K sh	—	—	16,083
2020-06-11	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.5K sh	—	—	28,500
2020-05-14	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-01-22	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
May 224
Nicholson Garry A0001193125-26-236854
SEC(opens sec.gov)
Apr 234
Nicholson Garry A0001640861-26-000001
SEC(opens sec.gov)
Nov 74
Nicholson Garry A0001640861-25-000004
SEC(opens sec.gov)
Jul 24
Nicholson Garry A0000950170-25-093057
SEC(opens sec.gov)
Jun 44
Nicholson Garry A0001415889-25-015622
SEC(opens sec.gov)
Sep 184
Nicholson Garry A0000950170-24-107797
SEC(opens sec.gov)

Companies

Address

C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET

WALTHAM, MA, 02451